A Search Service for Abbreviation / Long Form

â–  Search Result - Abbreviation : TNF

Search Conditions:
Search Keyword : TNF
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: TNF
Appearance Frequency: 29772 time(s)
Long forms: 83

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
tumor necrosis factor
(29555 times)
Allergy and Immunology
(5036 times)
IL (8390 times)
LPS (3009 times)
IFN (2513 times)
1978 Tumour-necrosis factor from the rabbit. II. Production by monocytes.
TNF-alpha
(59 times)
Allergy and Immunology
(18 times)
LPS (5 times)
IL-1 (3 times)
TNF-alpha (3 times)
1989 Tumor necrosis factor-mediated cytotoxicity by tumor-associated macrophages.
tumor necrosis factor/cachectin
(29 times)
Allergy and Immunology
(9 times)
LPS (6 times)
IL-1 (5 times)
IFN-gamma (3 times)
1986 Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1.
2,4,7-trinitro-9-fluorenone
(22 times)
Chemistry
(12 times)
CT (5 times)
CTC (4 times)
DLC (2 times)
1983 Genotoxic properties of 2,4,7-trinitro-9-fluorenone.
tenofovir
(14 times)
Pharmacology
(5 times)
ICH (2 times)
NRTIs (2 times)
RSD (2 times)
2003 Thymidine analogue-sparing highly active antiretroviral therapy (HAART).
treatment with antitumour necrosis factor
(7 times)
Dermatology
(2 times)
IL (2 times)
RA (2 times)
AS (1 time)
2009 [Sequential histological and immunohistochemical assessment of proliferation and apoptotic markers during treatment of psoriasis with antitumor necrosis factor alpha (infliximab)].
trinitrofluorenone
(4 times)
Toxins, Biological
(1 time)
2AA (1 time)
CT (1 time)
NOAEL (1 time)
1989 Genotoxicity and genotoxic enhancing effect of tetrandrine in Salmonella typhimurium.
TNF-alpha and TNF-beta
(3 times)
Communicable Diseases
(1 time)
TNF-alpha (2 times)
ACD (1 time)
CD (1 time)
1990 Expression of two distinct cytolytic mechanisms among murine CD4 subsets.
Tapajos National Forest
(2 times)
Environmental Health
(2 times)
GIS (1 time)
2006 Nitrous oxide nitrification and denitrification 15N enrichment factors from Amazon forest soils.
10  tiger nut fibre
(2 times)
Nutritional Sciences
(2 times)
--- 2010 Effect of tiger nut fibre on quality characteristics of pork burger.
11  transferrin
(2 times)
Medicine
(1 time)
ALB (2 times)
PA (2 times)
GOO (1 time)
1992 [The importance of a diet survey in the early detection of malnutrition in the elderly].
12  tumor necrosis-inducing factor
(2 times)
Cell Biology
(1 time)
DMSO (1 time)
FELC (1 time)
1982 Murine tumor necrosis-inducing factor: purification and effects on myelomonocytic leukemia cells.
13  2,4,5,7-tetranitrofluorescein
(1 time)
Molecular Biology
(1 time)
CTAC (1 time)
DMSO (1 time)
2005 2,4,5,7-Tetranitrofluorescein in solutions: novel type of tautomerism in hydroxyxanthene series as detected by various spectral methods.
14  9-dicyanomethylene-2,4,7-trinitrofluorene
(1 time)
Chemistry
(1 time)
--- 2008 Molecular clips with extended aromatic sidewalls as receptors for electron-acceptor molecules. Synthesis and NMR, photophysical, and electrochemical properties.
15  anti-(alpha)-tumor necrosis factor
(1 time)
Ophthalmology
(1 time)
CM (1 time)
ELISA (1 time)
hRPE (1 time)
1997 Human retinal pigment epithelial cell interleukin-8 and monocyte chemotactic protein-1 modulation by T-lymphocyte products.
16  anti-tumor necrosis factor inhibitor
(1 time)
Rheumatology
(1 time)
BS (1 time)
2017 A long-term follow-up of Japanese mother and her daughter with Blau syndrome: Effective treatment of anti-TNF inhibitors and useful diagnostic tool of joint ultrasound examination.
17  bisporphyrin-trinitrofluorenone
(1 time)
Biology
(1 time)
--- 2017 Sequence-controlled supramolecular terpolymerization directed by specific molecular recognitions.
18  HAT6-trinitrofluorenone
(1 time)
Nanotechnology
(1 time)
--- 2015 Columnar liquid crystals in cylindrical nanoconfinement.
19  IFN-beta+IL-1beta+tumor necrosis factor
(1 time)
Complementary Therapies
(1 time)
IFN (1 time)
IL (1 time)
iNOS (1 time)
2013 Suppressor of cytokine signaling 1 protects rat pancreatic islets from cytokine-induced apoptosis through Janus kinase/signal transducers and activators of transcription pathway.
20  interleukin-10:Tumor necrosis factor
(1 time)
Communicable Diseases
(1 time)
IL (1 time)
IL-10 (1 time)
2000 Plasma interleukin-10:Tumor necrosis factor (TNF)-alpha ratio is associated with TNF promoter variants and predicts malarial complications.
21  intra-tracheal instillation in each mouse of treated
(1 time)
Physiological Phenomena
(1 time)
PBS (1 time)
RARs (1 time)
TNF-alpha (1 time)
2017 Hypersensitivity of Vagal Pulmonary Afferents Induced by Tumor Necrosis Factor Alpha in Mice.
22  lentivirus‑tumor necrosis factor
(1 time)
Molecular Biology
(1 time)
COX (1 time)
MMP (1 time)
PBS (1 time)
2015 Targeted knockout of TNF-alpha by injection of lentivirus-mediated siRNA into the subacromial bursa for the treatment of subacromial bursitis in rats.
23  serum-tuberculostasis neutralizing factor
(1 time)
Allergy and Immunology
(1 time)
Tr (1 time)
1971 Mechanism of Tuberculostasis in Mammalian Serum III. Neutralization of Serum Tuberculostasis by Mycobactin.
24  T-cell depletion and antitumour necrosis factor
(1 time)
Dermatology
(1 time)
OS (1 time)
2009 A comprehensive review of biomarkers in psoriasis.
25  tacrolimus, and antitumor necrosis factor
(1 time)
Drug Therapy
(1 time)
JCA (1 time)
MMF (1 time)
VKH (1 time)
2006 Mycophenolate mofetil as an immunosuppressive agent in refractory inflammatory eye disease.
26  tactile nerve fiber
(1 time)
Neurosciences
(1 time)
TENS (1 time)
2017 A 3D Computational Model of Transcutaneous Electrical Nerve Stimulation for Estimating Abeta Tactile Nerve Fiber Excitability.
27  tapered optical nanofiber
(1 time)
Medicine
(1 time)
--- 2008 Observation of nonlinear optical interactions of ultralow levels of light in a tapered optical nanofiber embedded in a hot rubidium vapor.
28  target for antitumor necrosis factor
(1 time)
Chemistry
(1 time)
NF-kappaB (1 time)
2017 Discovery of Potent Small-Molecule Inhibitors of Ubiquitin-Conjugating Enzyme UbcH5c from alpha-Santonin Derivatives.
29  tenofovir disoproxil fumarate
(1 time)
Drug Therapy
(1 time)
CI range (1 time)
EMT (1 time)
2016 Comparative bioavailability of two tablet formulations of emtricitabine/tenofovir in healthy, fasting volunteers: a single-dose, randomized-sequence, open-label crossover study.
30  tetranucleotide frequency
(1 time)
Microbiological Phenomena
(1 time)
GH (1 time)
2013 Coupled high-throughput functional screening and next generation sequencing for identification of plant polymer decomposing enzymes in metagenomic libraries.
31  TF and cytokines
(1 time)
Vascular Diseases
(1 time)
PMN (1 time)
TF (1 time)
1998 [Modulators of leukocytic functions].
32  than a decade ago, antitumor necrosis factor
(1 time)
Biochemistry
(1 time)
ADAbs (1 time)
IBD (1 time)
2014 TNF blocking therapies and immunomonitoring in patients with inflammatory bowel disease.
33  Therapeutic Nursing Function
(1 time)
Nursing
(1 time)
--- 1986 Indicators of quality in nursing care--an alternative approach.
34  therapy with adalimumab, an antitumor necrosis factor
(1 time)
Medicine
(1 time)
DADS (1 time)
2015 DADS neuropathy associated with anti-TNF-alpha therapy.
35  Thermal Neutron Facility
(1 time)
Nuclear Medicine
(1 time)
--- 2015 Characterisation of the TRIUMF neutron facility using a Monte Carlo simulation code.
36  thickened nuchal fold
(1 time)
Obstetrics
(1 time)
EIF (1 time)
2017 The recurrence of sonographic 'soft markers': ominous sign or 'just' genetics?
37  thousand for a clay-rich Oxisol
(1 time)
Environmental Health
(1 time)
--- 2006 Nitrous oxide nitrification and denitrification 15N enrichment factors from Amazon forest soils.
38  thousand for a sandier Ultisol
(1 time)
Environmental Health
(1 time)
--- 2006 Nitrous oxide nitrification and denitrification 15N enrichment factors from Amazon forest soils.
39  thrombotic risk, whereas for antitumor necrosis factor
(1 time)
Hematology
(1 time)
IBD (1 time)
2016 Identification of an inflammatory bowel disease patient with a deep vein thrombosis and an altered clot lysis profile.
40  Thus, SM B cells produced pro-inflammatory
(1 time)
Medicine
(1 time)
BCDT (1 time)
DN (1 time)
RA (1 time)
2015 Expansion of Activated Peripheral Blood Memory B Cells in Rheumatoid Arthritis, Impact of B Cell Depletion Therapy, and Biomarkers of Response.
41  TiN nanofiber
(1 time)
Nanotechnology
(1 time)
ADT (1 time)
NPs (1 time)
ORR (1 time)
2015 Highly efficient and durable TiN nanofiber electrocatalyst supports.
42  titanate nano-fibrous
(1 time)
Biology
(1 time)
GAC (1 time)
PPS (1 time)
2017 Removing heavy metals using permeable pavement system with a titanate nano-fibrous adsorbent column as a post treatment.
43  titanate nanofiber
(1 time)
Environmental Health
(1 time)
GO (1 time)
2017 Processable graphene oxide-embedded titanate nanofiber membranes with improved filtration performance.
44  TNF gene
(1 time)
Dermatology
(1 time)
--- 2017 Immunology and genetics of tumour necrosis factor in allergic contact dermatitis.
45  TNF group and BCT group
(1 time)
General Surgery
(1 time)
BCT (1 time)
RT-PCR (1 time)
TNF-alpha (1 time)
2005 [Synergistic effect of bromocriptine combining tumor necrosis factor-alpha on reversing multidrug resistance in a nude mouse model of liver neoplasm].
46  TNF Mab
(1 time)
Cardiology
(1 time)
--- 1992 Efficacy of monoclonal antibody against tumor necrosis factor alpha in an endotoxemic baboon model.
47  TNF ratio
(1 time)
Medicine
(1 time)
--- 2000 Tumour necrosis factor alpha in the diagnostic assessment of pleural effusion.
48  TNF-alpha and LT-alpha
(1 time)
Allergy and Immunology
(1 time)
LT (1 time)
RAG (1 time)
1999 Nonlymphocyte-derived tumor necrosis factor is required for induction of colitis in recombination activating gene (RAG)2(-/-) mice upon transfer of CD4(+)CD45RB(hi) T cells.
49  TNF-alpha inhibitors
(1 time)
Gastroenterology
(1 time)
CD (1 time)
2018 Re-evaluating osteoporosis and fracture risk in Crohn's disease patients in the era of TNF-alpha inhibitors.
50  TNF-alpha/cachectin
(1 time)
Allergy and Immunology
(1 time)
Eos (1 time)
EPO (1 time)
HUVEC (1 time)
1990 Tumor necrosis factor alpha/cachectin stimulates eosinophil oxidant production and toxicity towards human endothelium.
51  TNFA and TNFB
(1 time)
Genetics, Medical
(1 time)
SNP (1 time)
2004 Association of tumor necrosis factor polymorphisms with asthma and serum total IgE.
52  TNFgradient
(1 time)
Pulmonary Medicine
(1 time)
CPPE (1 time)
UCPPE (1 time)
2005 The role of pleural fluid-serum gradient of tumor necrosis factor-alpha concentration in discrimination between complicated and uncomplicated parapneumonic effusion.
53  TNFpf
(1 time)
Pulmonary Medicine
(1 time)
CPPE (1 time)
UCPPE (1 time)
2005 The role of pleural fluid-serum gradient of tumor necrosis factor-alpha concentration in discrimination between complicated and uncomplicated parapneumonic effusion.
54  TNFserum
(1 time)
Pulmonary Medicine
(1 time)
CPPE (1 time)
UCPPE (1 time)
2005 The role of pleural fluid-serum gradient of tumor necrosis factor-alpha concentration in discrimination between complicated and uncomplicated parapneumonic effusion.
55  TNFtg mice
(1 time)
Neurology
(1 time)
DRG (1 time)
TNFR1 (1 time)
TTX-R (1 time)
2017 Chronic exposure to tumor necrosis factor in vivo induces hyperalgesia, upregulates sodium channel gene expression and alters the cellular electrophysiology of dorsal root ganglion neurons.
56  tolerate another antitumor necrosis factor
(1 time)
Gastroenterology
(1 time)
DILE (1 time)
IBD (1 time)
2011 Characterization of patients with infliximab-induced lupus erythematosus and outcomes after retreatment with a second anti-TNF agent.
57  tolnaftate
(1 time)
Chemistry Techniques, Analytical
(1 time)
beta-CD (1 time)
SLS (1 time)
2006 Highly sensitive and selective spectrofluorimetric determination of tolnaftate through the formation of ternary inclusion complex of beta-naphthol/beta-cyclodextrin/anionic surfactant system.
58  total number of muscle fiber
(1 time)
Food Technology
(1 time)
CSAF (1 time)
2016 Effects of Morphological Characteristics of Muscle Fibers on Porcine Growth Performance and Pork Quality.
59  toxin-neutralizing factor
(1 time)
Allergy and Immunology
(1 time)
--- 1972 Murine typhus toxin: studies on identification of the neutralizing factor present in normal human serum.
60  transcription factor controlling necrosis factor
(1 time)
Allergy and Immunology
(1 time)
HNF (1 time)
LITAF (1 time)
LPS (1 time)
2006 Cloning and characterization of lipopolysaccharide-induced tumor necrosis factor alpha factor promoter.
61  transcripts involved inflammatory cytokines
(1 time)
Molecular Biology
(1 time)
PLAC8 (1 time)
2006 Large-scale transcriptional analysis of bovine embryo biopsies in relation to pregnancy success after transfer to recipients.
62  transforming growth factor
(1 time)
Nephrology
(1 time)
ACE (1 time)
RAS (1 time)
SPARC (1 time)
2001 Role of angiotensin II in tubulointerstitial injury.
63  transforming necrosis factor
(1 time)
Gynecology
(1 time)
IL (1 time)
LPS (1 time)
2014 Differential response to lipopolysaccharide by JEG-3 and BeWo human choriocarcinoma cell lines.
64  transforming nuclear factor
(1 time)
Allergy and Immunology
(1 time)
ASL (1 time)
CFTR (1 time)
ENaC (1 time)
2013 Modulation of ENaC, CFTR, and iNOS expression in bronchial epithelial cells after stimulation with Staphylococcus epidermidis (94B080) and Staphylococcus aureus (90B083).
65  transitory neurological findings
(1 time)
Embryology
(1 time)
--- 1993 Transitory neurological findings in a population of at risk infants.
66  treated with intravenous injections of infliximab, an antitumor necrosis factor
(1 time)
Ophthalmology
(1 time)
BCVA (1 time)
BRVO (1 time)
RA (1 time)
2010 Regression of macular edema secondary to branch retinal vein occlusion during anti-TNF-alpha therapy for rheumatoid arthritis.
67  treated with monoclonal antitumor necrosis factor
(1 time)
Rheumatology
(1 time)
AAL (1 time)
CRP (1 time)
RA (1 time)
2007 Fucosylation of serum alpha1-acid glycoprotein in rheumatoid arthritis patients treated with infliximab.
68  treating MFH cells with LPS
(1 time)
Biology
(1 time)
MFH (1 time)
1995 Tumor necrosis factor accounts for the neutrophil emigration activity released by cultured malignant fibrous histiocytoma cells.
69  treatment on bone metabolism in antitumour necrosis factor
(1 time)
Gastroenterology
(1 time)
IBD (1 time)
IFX (1 time)
OC (1 time)
2016 A 1-year prospective study of the effect of infliximab on bone metabolism in inflammatory bowel disease patients.
70  treatment, following failure of antitumour necrosis factor
(1 time)
Medicine
(1 time)
ACPA (1 time)
DAS (1 time)
Ig (1 time)
2016 Serological markers associated with disease activity in patients with rheumatoid arthritis treated with rituximab.
71  triangular neighborhood function
(1 time)
Neurology
(1 time)
ASIC (1 time)
GNF (1 time)
SOMs (1 time)
2012 A programmable triangular neighborhood function for a Kohonen self-organizing map implemented on chip.
72  true negative fraction
(1 time)
Biomedical Engineering
(1 time)
CCA (1 time)
FNF (1 time)
FPF (1 time)
2012 Segmentation of atherosclerotic carotid plaque in ultrasound video.
73  tumor necrosis factor a microsatellite
(1 time)
Allergy and Immunology
(1 time)
--- 1997 Novel compound tetra-, dinucleotide microsatellite polymorphism in the tumor necrosis factor/lymphotoxin locus.
74  tumor necrosis factor alpha-induced protein
(1 time)
Biochemistry
(1 time)
5'-AzaC (1 time)
ALN (1 time)
Anx5 (1 time)
2015 Effects of 5'-azacytidine and alendronate on a hepatocellular carcinoma cell line: a proteomics perspective.
75  Tumor Necrosis Factor-(Formula: see text)
(1 time)
Medicine
(1 time)
TB (1 time)
2013 The roles of immune memory and aging in protective immunity and endogenous reactivation of tuberculosis.
76  Tumor Necrosis Factor-a pi
(1 time)
Neoplasms
(1 time)
HPP (1 time)
IHHP (1 time)
1998 TNF alpha in isolated perfusion systems: success in the limb, developments for the liver credits, debits and future perspectives.
77  tumor necrosis factor-alpha promoter
(1 time)
Rheumatology
(1 time)
ANCA (1 time)
MPA (1 time)
MPO (1 time)
2003 Genetic background of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis: association of HLA-DRB1*0901 with microscopic polyangiitis.
78  tumor necrosis factor-encoding gene
(1 time)
Molecular Biology
(1 time)
3'-UTR (1 time)
1993 Polymorphism of the mouse TNF-alpha locus: sequence studies of the 3'-untranslated region and first intron.
79  tumor necrosis factors -alpha and beta
(1 time)
Gynecology
(1 time)
--- 2010 [Tumor necrosis factor in uterine leiomyomas at various stages of tumor growth].
80  tumor nuclear factor
(1 time)
Endocrine System Diseases
(1 time)
CAD (1 time)
HDL (1 time)
HOMA-IR (1 time)
2014 Association of metabolic syndrome with severity of coronary artery disease.
81  tumor, rhTNF alpha
(1 time)
Neoplasms
(1 time)
CEA (1 time)
mAb (1 time)
1993 Tumor-necrosis factor can enhance radio-antibody uptake in human colon carcinoma xenografts by increasing vascular permeability.
82  tumour-necrosis-factor-like
(1 time)
Medicine
(1 time)
--- 1987 Evidence for tumour necrosis factor/cachectin production in cancer.
83  Turmeric nanofiber
(1 time)
Biomimetics
(1 time)
ASF (1 time)
CUR (1 time)
DSS (1 time)
2017 Preparation, characterization and anti-colitis activity of curcumin-asafoetida complex encapsulated in turmeric nanofiber.